INTRODUCTION
distinct from that present in erythrocytes (Poole et al., 1989 (Poole et al., , 1990 Wang et al., 1993 Wang et al., , 1994 . Furthermore, the relative Most tumour cells produce the ATP that they require for their insensitivity to inhibition by 4,4'-di-isothiocyanostilbene-2,2'-growth and cell division by glycolytic conversion of glucose into disulphonate (DIDS) and 4-acetimido-4'-isothiocyanostilbenelactic acid, rather than by total oxidation of glucose around the 2,2'-disulphonate (SITS) of lactate transport into liver cells and citric acid cycle (McKeehan, 1982; Newsholme et al., 1985;  sarcolemmal vesicles from skeletal muscle suggests that yet other Gonzalez-Mateos et al., 1993) . Such anaerobic metabolism may isoforms may exist in these tissues (Edlung and Halestrap, 1988 ; represent an advantage for rapidly growing tumours, whose Roth and Brooks, 1990; Juel, 1991) . Earlier studies on Ehrlich vascular supply might prove inadequate for the provision of ascites-tumour cells showed that they also possess a protonsufficient oxygen for ATP synthesis through oxidative linked monocarboxylate carrier (Spencer and Lehninger, 1976 ; phosphorylation. However, the resulting high rates of glycolysis Belt et al., 1979; Johnson et al., 1980) . However, the lack of lead to the formation of large quantities of lactic acid, which stereoselectivity for L-over D-lactate, and a Km for pyruvate must leave the cell rapidly. If this were to be prevented, the substantially higher than has been observed in other tissues accumulation of lactic acid within the cell would cause intra- (Spencer and Lehninger, 1976) , suggest that this might be yet cellular acidification and consequent inhibition of glycolysis.
another distinct isoform of the carrier. If evidence could be found Extensive work from this and other laboratories has identified for a unique isoform in tumour cells, it might provide a locus for the existence of a family of monocarboxylate transporters which effective chemotherapy. Indeed, inhibition of lactic acid efflux catalyse the net transport of lactic acid and a wide range of other from Ehrlich ascites cells with bioflavonoids such as quercetin short-chain monocarboxylic acids across cell plasma membranes has been shown to decrease intracellular pH (pH,) and hence to (see Poole and Halestrap, 1993) . The best characterized of these inhibit glycolysis and cell growth (Belt et al., 1979 ). Thus we is that found in erythrocytes. In isolated heart cells, studies of the decided to characterize monocarboxylate transport into these kinetics and substrate and inhibitor specificities of monocells more fully by performing a detailed study of the kinetics of carboxylate transport have led us to propose that there are two the carrier for a range of substrates and inhibitors. For this additional isoforms of the carrier present in these cells, both purpose we have developed a continuous fluorimetric assay
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of transport, using the intracellular pH indicator 2',7'-bis-(carboxyethyl)-5(6)-carboxyfluorescein (BCECF).
Since lactate transport involves co-transport of a proton, its uptake into cells will be accompanied by a slight acidification, which can be detected using BCECF. This has already been demonstrated by others in several cell types, although detailed kinetic studies have not been reported (Bonanno, 1990; Best et al., 1992; Cairns et al., 1993; Nedergaard and Goldman, 1993; Sekine et al., 1994) . We have recently developed the technique successfully for use in single isolated heart cells and demonstrated that kinetic parameters measured this way are in excellent agreement with those measured by conventional radioactive procedures (Wang et al., 1993 (Wang et al., , 1994 . Indeed, since fluorescence can be measured continuously with a very rapid time resolution, the technique both produces more accurate measurements of transport rates and allows them to be made at higher, more physiological, temperatures. Furthermore, the technique can be used to study the proton-linked transport of any monocarboxylate, since it is not dependent on obtaining the substrate in a radioactively labelled form. In the present studies, these advantages are used to the full to characterize the kinetics of transport of a wide range of substrates and the inhibition produced by a range of inhibitors. Our results represent the most complete study of the substrate specificity of any lactate carrier studies to date, and strongly suggest that the isoform present in tumour cells is the same as that found in erythrocytes.
EXPERIMENTAL Materials
Chemicals and biochemicals were obtained from sources given previously Halestrap, 1988, 1991; , with the following additions. BCECF, acetoxymethyl ester (BCECF/AM) was obtained from Calbiochem, Nottingham, U.K., or Boehringer Mannheim U.K., Lewes, East Sussex, U.K. Minimal Essential Medium (with Earle's salts) and newborn-calf serum (heat-inactivated) were obtained from Gibco BRL (Life Technologies), Paisley, Renfrewshire, Scotland, U.K. Benzylpenicillin sodium was obtained from Britannia Pharmaceutica, Redhill, Surrey, U.K., and streptomycin sulphate was obtained from Evans Medical, Horsham, West Sussex, U.K. Sodium butyrate, trimethylamine/HCl and nigericin were obtained from Sigma Chemical Co., Poole, Dorset, U.K. 4-Nitro-4'-benzamidostilbene-2,2'-disulphonate (NBDS) was generously given by Dr. R. C. Poole of this Department and was synthesized from 4-nitro-4'-aminostilbene-2,2'-disulphonate by the same methodology as used to synthesize 4,4'-dibenzamidostilbene-2,2'-disulphonate (DBDS) (Wang et al., 1993) . Ehrlich-Lettre mouse ascites-tumour cells (Lettre et al., 1972) were kindly donated by Dr. C. L. Bashford, Department of Biochemistry, St George's Hospital Medical School, London SW17 ORE, U.K.
Cell culture Ehrlich-Lettre ascites cells were initially isolated from white Balb/C mice 7-10 days after intraperitoneal implantation and diluted into 20 ml of PBS containing heparin (2 international units/ml). The cells were sedimented by centrifugation at 600 g for 10 min and resuspended in 20 ml of PBS, from which they were taken for culture in 75 cm2 flasks containing 50ml of medium A [Minimal Essential Medium with Earle's salts, containing 10% (v/v) newborn-calf serum, 50 units/ml penicillin, 50 u4g/ml streptomycin, 2 mg/ml D-glucose and 0.6 mg/ml Lglutamine) at 37°C under an atmosphere of air/CO2 (19: 1). The initial cell density was approx. 2 x I05 cells per flask, and reached 5 x 107 cells per flask after 8 days culture with a change of medium every 2 days. Cells were maintained at this density and harvested by a 1:2 split, half being used for subculture and half sedimented by centrifugation followed by resuspension of the cells from eight culture vessels in 20 ml of PBS. Cells were used from passage nos. 10-90 without any detectable change in their behaviour.
Preparation of cells for fluorimetric measurements
The harvested cells were washed once in PBS and twice in a standard assay buffer (see below). In each case cells were incubated at 6°C for 20 min before centrifugation, to remove all endogenous lactate. This is important to ensure transport of monocarboxylates is measured under zero-trans conditions . The standard buffer used was slightly modified from that employed by Lambert et al. (1989) for Ehrlich ascites-tumour cells, and contained 150 mM Na+, 5 mM K+, 150 mM Cl-, 1 mM Ca2 , 1 mM sulphate, 1 mM phosphate, 3.3 mM Mops, 3.3 mM Tris and 5 mM Hepes. The buffer was adjusted to pH 7.4 at 25°C with NaOH. Cells (1 x 107/ml) were loaded with BCECF by incubation for 30 min at room temperature in buffer containing 10,tM BCECF/AM before washing three times in standard buffer to remove extracellular BCECF. The loaded cells were stored on ice, protected from light, at 1 x I07 cells/ml until use, and showed no detectable deterioration for at least 3 h.
Measurement of monocarboxylate transport
To 3 ml of buffer contained in a 4 ml fluorescence cuvette was added a 0.5 ml portion of the cells loaded with BCECF (final concentration of approx. 1.5 x 106 cells/ml). The cells were kept in suspension by constant stirring using an overhead paddlestirrer integral to the cuvette holder of the fluorimeter, which was maintained at the required temperature (usually 25°C) by water circulation. The fluorescence was measured with a modified double-beam spectrophotometer which allowed dual-wavelength excitation, the incident light switching between 450 and 500 nm (2 rm slit widths) at a frequency of 397 Hz by means of an oscillating mirror. The emitted light was passed through an optical cut-off filter (> 520 nm) on to a photomultiplier tube orientated at 900 to the incident light and in close proximity to the cuvette. The ratio of fluorescent light corresponding to the two excitation wavelengths (the '450/500' ratio) was determined electronically and the resulting signal averaged by computer to give 2 data points per second, which were displayed in real time and stored for further data analysis using our own software. The '450/500' ratio provides a measure of pH, which minimizes errors due to light-scattering of the sample and loss of BCECF from the cell by bleaching or diffusion (Eisner et al., 1989) . Once the fluorescence signal from the cell suspension had reached a steady state, usually after 1 min, substrates (neutralized as the sodium salts) were added to the suspension through a lightsealed addition port, and the subsequent fluorescence change was monitored. The initial rate of the fluorescence change was determined by fitting the data to a first-order progress curve by using Fig P and PFit software (Biosoft, Cambridge, U.K.). The first two data points were omitted, since these incorporated errors associated with the mixing time and addition artefacts.
Whenever additions of coloured reagents were made to the standard assay buffer, it was confirmed that these had no effect on the '450/500' fluorescence ratio.
Calibration and measurement of pH gradients
To calibrate the BCECF 450/500 fluorescence ratio in terms of pHi, two techniques were employed. For the most accurate calibration the standard buffer was replaced with one in which 150 mM K+ was substituted for 150 mM Na+ and the K+/H+ ionophore nigericin (5 ,uM) was added to equilibrate pHi with extracellular pH (pH.) ). The cell suspension was then titrated with sequential additions of either HCl or NaOH, the 450/500 fluorescence ratio recorded and the pH of the medium measured with a pH electrode in a parallel incubation. The second method, which was used for routine measurements of pHi, was the 'null-point' technique (Eisner et al., 1989) . This avoids the use of nigericin and the associated risk of contaminating the apparatus with the ionophore. In this technique, defined mixtures of sodium butyrate (a weak permeant acid) and trimethylamine hydrochloride (a weak permeant base), were added to the cell suspension until a mixture was found that gave no change in fluorescence. The pHi was then calculated by using the formula derived by Eisner et al. (1989) . The two techniques consistently gave the same value for pHi of 7.3 under our normal incubation conditions.
Presentation of results
To calculate the rate of carrier-mediated transport, the initial rate of fluorescence change, determined by first-order curve fitting as described above, was corrected for free diffusion of the non-dissociated monocarboxylic acid by subtracting the rate observed in the presence of 5 mM a-cyano-4-hydroxycinnamate (see Poole and Halestrap, 1993) . Conversion of the rate of fluorescence change into a rate of proton uptake in nmol/,ul of intracellular volume was accomplished by using the pHJ fluorescence calibration curve and the calculated buffering power of the cells as explained in the Results and discussion section. Calculation of kinetic constants was performed by using nonlinear least-squares regression analysis to the relevant kinetic equation using Fig P and PFit software (Biosoft). These fits routinely produced standard errors for each parameter of < 20 % of the parameter value, but in most cases several experiments were performed on separate cell preparations and the derived parameter values were meaned and expressed as mean + S.E.M.
RESULTS AND DISCUSSION
Calibration of BCECF signal for measurement of pH, and proton uptake Cells incubated in a high-[K+] medium in the presence of nigericin to allow rapid K+/H+ exchange across the plasma membrane equilibrate their pHi with the pH of the medium . Measurement of the external pH and the BCECF 450/500 fluorescence ratio with sequential additions of either HCl or NaOH allowed calibration of the fluorescence ratio in terms of pHi as shown in Figure 1 . No correction was made for autofluorescence, since this was found to be less than 100% of the BCECF fluorescence signal at both wavelengths, and showed no change under any of the conditions used. The change in fluorescence ratio with pH obeyed a linear relationship over the pH range used in the present experiments, with a slope of 245.5 mV/pH unit. This value was extremely consistent from day to day, as indicated by the very low errors shown in Figure  1 . In order to convert the perturbation of pH1 observed upon monocarboxylate addition to cells into nmol of H+/monocarboxylate transported, the maximum changes in fluorescence ratio observed after addition of increasing concentrations of butyrate were determined. Data are illustrated in Figure 2 , where the fluorescence change in mV is plotted against [butyrate] . In three such experiments, the mean initial slope (± S.E.M.) of the curve obtained was 14.35 + 0.41 mV/mM butyrate added. Butyrate equilibrates rapidly across the membrane by free diffusion of the undissociated acid, and this was confirmed by demonstrating that addition of 5 mM a-cyano-4-hydroxycinnamate (CHC) to inhibit the monocarboxylate transporter had no effect on the change in fluorescence signal observed. . By combining the data of Figures  1 and 2 , it is also possible to calculate the buffering power of the cells under our conditions, which was 13.7 mM H+/pH unit.
Lactate/proton stoichiometry of transport
In Figure 2 we also show that the total change in fluorescence that occurs after the addition of low concentrations of L-lactate is the same as that induced by butyrate at the same concentration.
Since the entry of butyrate is known to occur by free diffusion of the undissociated acid, and therefore must have a stoichiometry of 1 proton per butyrate molecule, it follows that the uptake of lactate must also occur with the same stochiometry. Although this has been assumed, the present data formally prove it. At higher lactate concentrations the fluorescence change at equilibrium is slightly less than that caused by butyrate. This probably reflects pH-regulatory mechanisms operating to decrease the acid load induced by the monocarboxylate. Because butyrate enters the cell much more rapidly than lactate at higher concentrations, these compensating mechanisms decrease the equilibrium pH change caused by butyrate less than they do that for lactate. (Halestrap and McGivan, 1979 Measurement of transport kinetics and substrate specmcity
The data of Figure 3 show the changes in pH, associated with the addition of increasing concentrations of L-lactate to BCECFloaded cells in the absence (Figure 3a ) and presence (Figure 3b ) of 5 mM CHC. At all concentrations of lactate used in the present experiments, CHC gave > 90 % inhibition of the rate of lactate transport. To determine the initial rates of transport accurately, and so derive kinetic constants, the time courses of the fluorescence changes were fitted to a first-order rate equation by non-linear least-squares regression, as illustrated in Figure  4 (a); the fit of the data is very good. In order to determine the kinetic parameters for the transporter, it was necessary to correct the initial rate of lactate uptake for the component occurring by free diffusion of the undissociated acid of transport rates at substrate concentrations both above and below the Km, the accuracy of the data fit is inevitably poorer. In addition, the inhibition by 5 mM CHC, which, although largely non-competitive, has some competitive component (see Table 4 appears to be through the carrier, since uptake was largely abolished by 5 mM CHC ( Figure 5 ). It should be noted that the data presented in Figure 5 are the first direct demonstrations that The kinetic parameters were determined at the temperature shown by using the protocol described in Figures 3 and 4 . The errors given are the S.E. of the parameters derived by leastsquares regression analysis of the data (at least eight substrate concentrations) to the Michaelis-Menten equation after correction for the CHC-insensitive rate of transport. This was performed by using the value for kdift determined from the rates of transport measured in the presence of 5 mM CHC as described in Figure 4 . It is clear that the substrate specificity of both carriers is very similar. Thus both show significant stereoselectivity for Lover D-lactate, but not for L-over D-3-hydroxybutyrate or for Lover D-2-chloropropionate, although in the case of 3-hydroxybutyrate the Vmax for the D-isomer (the naturally occurring form) was found to be about twice that of the L-isomer. In rat erythrocytes, values (A. P. Halestrap, R. C. Poole and C. Mann, unpublished work) reported in Table 1 and those of others Anderson et al., 1978) have also suggested the D-isomer of 3-hydroxybutyrate to be the better substrate, but in this case it is a lower Km that is responsible. Both the tumour cell and erythrocyte carriers accept substitutions on C-2 or C-3, with substitution on C-2 with a chloro or oxo group greatly enhancing the affinity of the carrier for the substrate. The transporter also accepts double substitution of C-2 with chloride, as in dichloroacetate, or with the hydroxyl group, as in fluoropyruvate, which exists primarily in the diol form (Meany and Tienhaara, 1973) , but not when a methyl group is present, as in 2-hydroxy-2-methylpropionate. For both carriers oxamate, glyoxylate and formate are very poor substrates. In most instances, the Km values measured for the tumour cell carrier are similar to or a little higher than those measured for the erythrocyte carrier. Some differences may reflect the different species from which the cells are derived, erythrocytes from the rat and the tumour cells from the mouse. There may also be differences in the phospholipid composition between the two cell types, which can alter carrier kinetics (Grunze et al., 1980) . Another factor may be that the measurements with rat erythrocytes were performed at 6 'C, whereas those with the tumour cells were made at 25 'C. Deuticke (1982) has reported that the Km for lactate efflux from human erythrocytes is decreased as the temperature is lowered, and we have confirmed that is the case for the tumour cells, as shown in Table 2 .
There are two substrates whose kinetics of transport we have attempted to measure without success; these are a-ketoisocaproate (2-oxo-4-methylpentanoate) and a-ketoisovalerate (2-oxo-3-methylbutyrate), which are the transamination products of leucine and valine respectively. When these substrates were added to the BCECF-loaded cells there was a fast initial decrease in pH1, which slowed before the expected equilibrium had been reached. This is illustrated in Figure 6 . Addition of L-lactate after the initial response to these substrates gave a very much slower decrease in pHi than was observed if sequential additions of Llactate were made in their absence. These data support our previous suggestion that monocarboxylates with hydrophobic side chains may inhibit the transporter strongly by binding to an internal binding site with high affinity Halestrap, 1976; Poole and Halestrap, 1993) . It is envisaged that the substrate is transported by the carrier to the inner surface, where it may either be released rapidly, as is the case for most substrates, or form a tight-binding complex which prevents return of the empty carrier to the external-face of the plasma membrane. A similar mode of action is thought to operate for CHC, the most widely used inhibitor of monocarboxylate transport Halestrap, 1976; Leeks and Halestrap, 1978; Poole and Halestrap, 1993) . Surprisingly, phenylpyruvate did not demonstrate the same rapid uptake followed by inhibition, and appeared to show very little carrier- .
Inhibitors of L-lactate transport
The inhibition of the lactate transport into tumour cells by a variety of established inhibitors of the erythrocyte monocarboxylate transporter was investigated, and data are reported in Figure 7 and Tables 3 and 4 . In most cases a single concentration ofL-lactate was used (5 mM) and the concentration of inhibitor was varied. From such studies the data could be fitted well by least-squares regression analysis to the equation Table  3 , where data for the rat erythrocyte are also presented. The overall pattern of inhibitor potency is the same for both cell types, but the absolute values are significantly higher for the tumour cells than for the erythrocytes. The lower temperature (6°C) used in the erythrocyte studies might lead to a 2-3-fold lower K, than for the tumour cells, in analogous fashion to the effect of temperature on the Km value for L-lactate (Table 2 ).
However, two additional factors may also lead to substantial increases in the Ko.5 values observed in the present experiments.
Firstly they were performed at 5 mM L-lactate, which is just above the Km, rather than 0.5 mM (about one-fifth of the Km value) used for the erythrocyte studies. This was necessary to obtain accurate rates of change of pHi at higher inhibitor concentrations. Stilbene disulphonates are impermeant and probably inhibit transport by binding to the external substratebinding site ; this produces primarily competitive inhibition, as shown in Table 4 . Thus the K0_5 would be expected to be about 2-fold higher at 5 mM L-lactate than at 0.5 mM L-lactate. Secondly, the present experiments were performed in a saline medium in which the intracellular pH was similar to the extracellular pH, whereas in the erythrocyte experiments a citrate buffer was used to create a substantial pH gradient across the plasma membrane (0.6-0.8 pH unit alkaline inside). It was not possible to generate a similar pH gradient across the plasma membrane of tumour cells under such conditions (results not shown), and so direct comparison of data obtained in the presence and absence of a pH gradient was not possible. However, we have previously performed such experiments with human erythrocytes (Halestrap, 1976; Leeks and Halestrap, 1978) , where it was shown that the K, for CHC increased from about 50 ,M in citrate medium (pH gradient 0.8 unit alkaline inside) to 400-500 pM in saline medium (pH gradient 0.2 unit acid inside). A similar observation has been made for the effects of a transmembrane pH gradient on the inhibition of mitochondrial pyruvate transport by CHC and is believed to be a result of the inhibitor binding tightly to the inner surface of the carrier (Halestrap, 1978a,b) . This is favoured by an alkaline transmembrane gradient, which drives the carrier into the inward-facing conformation.
More detailed analyses of the inhibition by DBDS, CHC and phloretin, which represent three different classes of inhibitor, were performed by studying the inhibition of transport observed when concentrations of both L-lactate and inhibitor and inhibitor were varied. Results are reported in Table 4 . In all cases data were fitted to the equation for mixed inhibition and also for the simpler models of competitive and non-competitive inhibition. Where the simpler model gave as good a fit as for mixed inhibition (i.e. F value giving P < 0.05), this is noted and the single Ki value is quoted. Phloretin inhibition could be fitted well to a non-competitive model (i.e. Kil and K12 were similar), with a mean K1 of 6.9+0.5 ,uM (n = 3) compared with a value of 1.4 ,uM in rat erythrocytes (Wang et al., 1993 Ko5 values for the inhibitors were obtained as described in the legend to Figure 7 ; at least six concentrations of inhibitor were used, distributed either side of the KO5. Data for each individual experimental were filted by using non-linear least-squares regression analysis to the equations shown in Figure 7 legend. The co-operative model was only used for mersalyl and pchloromercuribenzenesulptonate (PCMBS). Where more than one experiment was performed, Ko5 values are given as the means+ S.E.M., with n values indicated in parentheses. Data for the rat erythrocyte are taken from Poole and Halestrap (1993) Initial rates of lactate transport were measured for at least five substrate and five inhibitor concentrations, and the data were filled to the equation for mixed inhibition by least-squares regression analysis, and the competitive and uncompetitive K/ values (K1 and K,2 respectively) were derived. For each inhibitor three separate experiments were performed, and the derived parameter values are presented as the means + S.E.M. The data were also filted to the simpler competitive and non-competitive models, and where statistical analysis (F value, P < 0.05) showed the simpler model to be as good a fit, this is indicated under the type of inhibition.
Where mixed inhibition gave a belter fit, this is shown together with the dominant component of the inhibition. In both cases the K4 value (±S.E.M.) for the simpler fit is also shown. (Halestrap, 1978a; Deves and Krupka, 1989; 1990) . In contrast, previous kinetic studies on the nature of CHC inhibition of the human erythrocyte lactate transporter reported competitive inhibition, but in those experiments CHC and lactate were added simultaneously (Halestrap, 1976 Table 4 . A similar pattern of inhibition was also found in rat erythrocytes , although, once again, the competitive K, value measured here is significantly higher than the value of 22 ,uM for rat erythrocytes .
Activation energy of the transporter The continuous assay of transport by using BCECF fluorescence makes it possible to measure transport rates accurately over a range of temperatures. This allows the rate of transport at physiological temperature and the activation energy for transport to be determined. The former value has been impossible to obtain directly by conventional radioactive techniques, which lack the necessary time resolution . The data presented in Figure 8 show (Halestrap, 1976; McGivan et al., 1977; Baur and Heldt, 1977 (Halestrap, 1976) , compared with the value of 19°C found in the present experiments. If this reflects a phase change in the membrane phospholipids, as has been suggested (Halestrap, 1976) , then the composition and properties of the tumour-cell and erythrocyte membranes may well differ sufficiently to account for some of the differences in the kinetics of the monocarboxylate carrier observed in the two cell types. We have recently purified the lactate carrier from rabbit erythrocytes sufficiently to obtain a 16-residue N-terminal amino acid sequence (Belt et al., 1979; Johnson et al., 1980; Gonzalez-Mateos et al., 1993; Halder et al., 1993) . Under the conditions used in the present studies the intracellular volume was found to be 1.98 + 0.16 ,u/mg of protein (mean + S.E.M. of 12 separate experiments) when determined with [14C]sucrose and 3H20. Thus the carrier would appear to have considerable spare capacity to allow for rapid efflux of the lactic acid produced by glycolysis. Nevertheless Belt et al. (1979) .
